CCR5: no longer a ‘good for nothing’ gene – chemokine control of West Nile virus infection
Authors:
- William G. GlassWGWilliam G. Glass
- David H. McDermottDMDavid H. McDermott
- Philip M. MurphyPMPhilip M. Murphy
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 27 (7) , 308-312
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- RNase L Plays a Role in the Antiviral Response to West Nile VirusJournal of Virology, 2006
- Association Between the CCR5 32-bp Deletion Allele and Late Onset of SchizophreniaAmerican Journal of Psychiatry, 2006
- Single Nucleotide Polymorphisms in Genes for 2′‐5′‐Oligoadenylate Synthetase and RNase L in Patients Hospitalized with West Nile Virus InfectionThe Journal of Infectious Diseases, 2005
- The Case for Selection at CCR5-Δ32PLOS Biology, 2005
- CCL3L1 dose and HIV-1 susceptibilityTrends in Molecular Medicine, 2005
- Different chemokine expression in lethal and non‐lethal murine west nile virus infectionJournal of Medical Virology, 2004
- Chemokines in rapid leukocyte adhesion triggering and migrationSeminars in Immunology, 2002
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in miceArchives of Virology, 1996